Filana Therapeutics
FLNA
46 hedge funds and large institutions have $10.9M invested in Filana Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 8 closing their positions.
5.93% more ownership
Funds ownership: 0% → 5.93% (+5.9%)
4% less funds holding
Funds holding: 48 → 46 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
48% less capital invested
Capital invested by funds: $20.9M → $10.9M (-$9.94M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$305K |
| 2 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$136K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$70K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$55.1K |
| 5 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
+$29.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$628K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$292K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$271K |
| 4 |
6CM
683 Capital Management
New York
|
-$270K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$156K |
FLNA Hedge Fund Activity: Q4 2016 in Review
46 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2016, worth a combined $10.9M — down 48% from $20.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FLNA and 6 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $305K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $628K sold.
- 46 institutional investors held Filana Therapeutics (FLNA) as of Q4 2016, down from 48 in Q3 2016.
- Funds reported $10.9M of Filana Therapeutics stock for Q4 2016, down 48% quarter-over-quarter.
- 6 funds opened new Filana Therapeutics positions in Q4 2016 and 8 closed out, a net change of -2 holders.
- The largest Filana Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $305K added.
- The largest Filana Therapeutics seller in Q4 2016 was Dimensional Fund Advisors, an estimated $628K sold.
Based on aggregated 13F filings for Q4 2016.